Patients' views of the burden of asthma: a qualitative study

Med J Aust. 2002 Sep 16;177(6):295-9. doi: 10.5694/j.1326-5377.2002.tb04786.x.

Abstract

Objectives: To explore the burden of asthma on the lives of people presenting to hospital emergency departments for asthma treatment.

Design: A qualitative study. Consenting individuals with asthma who presented to emergency departments were interviewed in-depth, and interviews were taped, transcribed and thematically analysed. Questionnaire data on medication use, respiratory health and asthma knowledge were also collected. Asthma severity was determined from the medical records.

Setting: A tertiary teaching hospital and a suburban hospital during March and April 2000, and a rural hospital during July and August 2000.

Participants: Sixty-two participants (19 male and 43 female), aged 18-70 years.

Results: The burden of asthma was broad, affecting social life, personal relationships, employment and finances. The cost of asthma medication was an issue for nearly two-thirds of participants. Individuals performed their own "cost-benefit analysis" for medication use, weighing up expense, perceived side effects and potential benefits. As a consequence, several participants chose to alter their medication dose, or not to take prescribed medications. For some participants, asthma directly contributed to diminished employment opportunities.

Conclusions: To achieve a therapeutic partnership, doctors need to be aware of the substantial social, personal and financial burden of asthma for their patients. They should also recognise that patients' perceptions of treatment cost may compromise treatment adherence.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anti-Asthmatic Agents / adverse effects
  • Anti-Asthmatic Agents / economics
  • Asthma* / economics
  • Australia
  • Drug Costs
  • Employment
  • Female
  • Health Care Costs*
  • Humans
  • Male
  • Middle Aged
  • Quality of Life*
  • Sick Leave / economics

Substances

  • Anti-Asthmatic Agents